Agenus Inc.
ANTI-CTLA-4 ANTIBODIES AND METHODS OF USE THEREOF
Last updated:
Abstract:
The instant disclosure provides antibodies that specifically bind to human CTLA-4 and antagonize CTLA-4 function. Also provided are pharmaceutical compositions comprising these antibodies, nucleic acids encoding these antibodies, expression vectors and host cells for making these antibodies, and methods of treating a subject using these antibodies.
Status:
Application
Type:
Utility
Filling date:
24 Jan 2022
Issue date:
25 Aug 2022